Analysis of clinical characteristics, toxicities and outcomes of hormone receptor positive, her 2 negative metastatic breast cancer patients treated with CDK4/6 inhibitors palbociclib from January 2016 till December 2018
Latest Information Update: 29 Jul 2020
At a glance
- Drugs Anastrozole (Primary) ; Fulvestrant (Primary) ; Letrozole (Primary) ; Palbociclib (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 29 Jul 2020 New trial record